Sexual and hormonal health
Low libido
Desire is affected by relationships, stress, medicines, hormones, pain and general health. Low desire is not the same as difficulty achieving an erection.
Potential benefits explored
Greater sexual desire and engagement.
PT-141 has defined low-desire human evidence; kisspeptin is an early sexual-response research option. Oxytocin concerns context-dependent social/emotional effects.
Practical interpretation
Assess medications, relationship context, distress, pain and relevant hormone issues. Nutrient replacement matters only where deficiency contributes to health or fatigue.
Meaningful outcomes: Desire, distress and satisfying sexual experiences.
Compare the compounds studied for Low libido
Members see the full evidence picture for this condition: every compound studied, graded per condition from strong human evidence through to preclinical-only and negative findings, with human and animal results, risks, combination evidence and cited sources — plus how each compound maps to the research materials we list, with live pricing and stock.
Research reference for laboratory materials only. Not medical advice and not a recommendation for human use. Research cut-off: 30 September 2026.